Stryker Impairment Charges increased by 32.7% to $73.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 3550.0%, from $2.00M to $73.00M. Over 2 years (FY 2022 to FY 2024), Impairment Charges shows an upward trend with a 112.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High impairment charges suggest poor capital allocation or a decline in the competitive value of the company's assets.
Impairment charges are non-cash write-downs taken when the carrying value of an asset exceeds its fair market value. Thi...
Common in industries with high intangible asset bases, such as pharma and consumer goods.
cf_impairment_charges| Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $105.00M | $0.00 | $0.00 | $105.00M | $111.00M | $2.00M | $1.00M | $9.00M | -$12.00M | $3.00M | $16.00M | $2.00M | $956.00M | $35.00M | $55.00M | $73.00M |
| QoQ Change | — | -100.0% | — | — | +5.7% | -98.2% | -50.0% | +800.0% | -233.3% | +125.0% | +433.3% | -87.5% | >999% | -96.3% | +57.1% | +32.7% |
| YoY Change | — | — | — | +0.0% | — | — | — | -91.4% | -110.8% | +50.0% | >999% | -77.8% | >999% | >999% | +243.8% | >999% |
We use cookies for analytics. See our Privacy and Cookie Policy.